阿尔茨海默病小鼠模型中的角膜免疫细胞改变与Tau病理
本研究利用5×FAD小鼠模型,系统表征了阿尔茨海默病相关角膜病理演变。结果显示角膜周边部出现树突状细胞形态简化、T细胞浸润、Tau过度磷酸化及神经丢失等时序性改变,提示角膜可能作为无创监测AD进展的位点。
要点
- 角膜树突状细胞形态简化最早在3月龄出现,早于细胞增多和T细胞浸润。
- Tau Thr181过度磷酸化在7月龄出现,伴随GSK3β活性增高。
- 10月龄时角膜神经末梢丢失,残余纤维磷酸化Tau负担显著升高。
核心结论
- 角膜神经免疫重塑表现为早期树突状细胞功能障碍、随后T细胞招募和Tau病理,早于明显的神经变性。
研究设计与样本
- 研究使用野生型和5×FAD小鼠(3、5、7、10月龄,包含两种性别)的角膜,采用全片免疫染色与3D重建、免疫印迹、RNA测序和质谱蛋白质组学等多模态方法进行分析。
主要发现
- 局部未检测到人APP产生,但周边角膜出现明确的时序性级联改变。
- 树突状细胞形态简化(周长和分支减少)最早在3月龄出现,早于5月龄的显著树突状细胞增多和7月龄的CD3⁺ T细胞浸润。
- Tau Thr181过度磷酸化在7月龄出现,同时伴随GSK3β活性增高(pGSK3β Ser9降低)。
- 10月龄时观察到周边部基底神经丛和浅层神经末梢显著丢失,残余纤维的磷酸化Tau负担明显升高。
- 7月龄的多组学分析验证了促炎状态,发现粘附分子ICAM1和ITGB2上调以及T细胞趋化因子IL-16。
临床怎么用
- 角膜可能作为无创可及的位点用于监测阿尔茨海默病进展,但需进一步人体研究验证。
局限性
- 研究仅基于5×FAD小鼠模型,结果向人类转化需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Early diagnosis of Alzheimer's disease (AD) remains a formidable challenge. Although retinal markers are extensively studied, the cornea-the eye's primary transparent window-presents a potential but poorly understood platform for biomarker discovery. This study systematically characterized AD-associated corneal pathological evolution using the 5 × FAD mouse model. METHODS: Corneas from wild-type (WT) and 5 × FAD mice (ages 3, 5, 7, and 10 months; both sexes included) were analyzed using multimodal approaches: whole-mount immunostaining with 3D reconstruction, immunoblotting, RNA sequencing, and mass spectrometry proteomics. RESULTS: Although local human APP production was absent, a defined temporal cascade emerged selectively in the peripheral cornea. Dendritic cell (DC) morphological simplification (reduced perimeter and branching) occurred as early as 3 months, preceding significant DC expansion at 5 months and CD3⁺ T cell infiltration at 7 months. Tau hyperphosphorylation (Thr181) surfaced at 7 months, coinciding with heightened GSK3β activity (reduced pGSK3β Ser9). By 10 months, significant peripheral subbasal nerve plexus and superficial nerve terminals loss were observed, with residual fibers exhibiting markedly elevated phosphorylated tau burden. Multi-omics at 7 months validated this pro-inflammatory state, identifying upregulated adhesion molecules (ICAM1 and ITGB2) and the T cell chemoattractant IL-16. CONCLUSIONS: Corneal neuro-immune remodeling-manifesting as early DC dysfunction followed by T cell recruitment and tau pathology-precedes overt nerve degeneration. These findings suggest the cornea as a potential, noninvasively accessible site for monitoring AD progression.
引用
- Zhang D, Huang D, He J, et al. Corneal Immune Cell Alterations and Tau Pathology in a Mouse Model of Alzheimer's Disease. Invest Ophthalmol Vis Sci. 2026. PMID: 42112683. doi:10.1167/iovs.67.5.20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。